Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)

BACKGROUND: Recent studies have shown that according to the expression levels of achaete-scute homolog 1 (ASCL1), neurogenic differentiation factor 1 (NEUROD1), and POU class 2 homeobox 3 (POU2F3), small cell lung cancer (SCLC) can be divided into four subtypes: SCLC-A (ASCL1-dominant), SCLC-N (NEUR...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xiao-Long, Su, Yi-Ge, Yu, Liang, Bai, Zhou-Lan, Bai, Xue-Hong, Chen, Xiao-Zhen, Yang, Xia, Zhao, Ren, He, Jin-Xi, Wang, Yan-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883717/
https://www.ncbi.nlm.nih.gov/pubmed/35220975
http://dx.doi.org/10.1186/s12957-022-02528-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883717/
https://www.ncbi.nlm.nih.gov/pubmed/35220975
http://dx.doi.org/10.1186/s12957-022-02528-y

Ejemplares similares